Application 214897
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS USA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMANTADINE | AMANTADINE | CAPSULE, EXTENDED RELEASE;ORAL | 65.5MG | No | No |
| 002 | AMANTADINE | AMANTADINE | CAPSULE, EXTENDED RELEASE;ORAL | 137MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A214897-001 | AMANTADINE HYDROCHLORIDE | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | AB | 2024-08-26 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A214897-001 | AMANTADINE HYDROCHLORIDE | EQ 68.5MG BASE | CAPSULE, EXTENDED RELEASE / ORAL | 2024-08-26 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A214897-001 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A214897-001 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A214897-001 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A214897-001 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A214897-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A214897-001 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A214897-001 | AB | 1 | d06236e962d9… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GOCOVRI | AMANTADINE | Supernus Pharmaceuticals, Inc. | 2bee0631-0028-1314-e063-6394a90aaaed | 2026-09-08 | Warnings, Adverse reactions | AMANTADINE |
| GOCOVRI | AMANTADINE | Adamas Pharma, LLC | 82ff865f-78f3-4c94-b6a9-727a54944b28 | 2026-09-08 | Warnings, Adverse reactions | AMANTADINE |
| Amantadine | AMANTADINE | American Health Packaging | 5119801d-a5cb-4adf-96b2-08cc3a0ba594 | 2026-06-23 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| Amantadine | AMANTADINE | Proficient Rx LP | 7aa6bc18-1cee-4b6d-b7c3-0bac6a924ece | 2026-02-01 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| Amantadine | AMANTADINE | NCS HealthCare of KY, LLC dba Vangard Labs | 2ff05131-f634-4688-86e9-9bc33a8d11c4 | 2026-01-23 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| Amantadine | AMANTADINE | AvPAK | 48c949e3-86e0-c639-e063-6294a90acdba | 2026-01-19 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| Amantadine | AMANTADINE | Alembic Pharmaceuticals Inc. | da1837b5-fda2-48e0-91ba-d6eb2b991b55 | 2025-07-28 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| amantadine | AMANTADINE | Alembic Pharmaceuticals Inc. | 4157d9a7-a53f-4dde-b051-fe3e9a674913 | 2025-06-04 | Warnings, Adverse reactions | amantadine AMANTADINE |
| Amantadine | AMANTADINE | Xttrium Laboratories, Inc | 25dd8a3c-6b11-2ea1-e063-6294a90a50cf | 2025-05-21 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| Amantadine | AMANTADINE | Coupler LLC | 303c5b9d-5761-9fcd-e063-6394a90a8a2b | 2025-03-13 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| Amantadine | AMANTADINE | Alembic Pharmaceuticals Limited | 48fa07c8-8b95-40d7-a0f5-132577dfb2c8 | 2023-01-27 | Warnings, Adverse reactions | Amantadine AMANTADINE |
| amantadine | AMANTADINE | Alembic Pharmaceuticals Limited | d8887814-3e56-447e-8bc3-add1861e0cf7 | 2023-01-27 | Warnings, Adverse reactions | amantadine AMANTADINE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 72739 | ORIG | 2022-11-28 |